Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections-Reference-Cited by-同舟云学术

Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections

Published:2019-02-12 Issue:6 Volume:321 Page:612
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Rodríguez-Baño Jesús¹,Gutiérrez-Gutiérrez Belén¹,Kahlmeter Gunnar²

Affiliation:

1. Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain

2. Clinical Microbiology, Central Hospital, Växjö, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference3 articles.

1. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial.;Harris;JAMA,2018

2. A multinational, preregistered cohort study of ß-lactam/ß-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-ß-lactamase-producing Enterobacteriaceae.;Gutiérrez-Gutiérrez;Antimicrob Agents Chemother,2016

3. European Committee on Antimicrobial Susceptibility Testing. EUCAST warnings concerning antimicrobial susceptibility testing products or procedures. http://www.eucast.org/ast_of_bacteria/warnings/. Accessed November 2, 2018.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use;World Journal of Emergency Surgery;2024-06-08

2. Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP;Antibiotics;2024-03-25

3. All-cause and Infection-attributable Mortality Amongst Adults With Bloodstream Infection—a Population-based Study;Open Forum Infectious Diseases;2024-03-06

4. Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study;Microorganisms;2024-01-12

5. Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study;Journal of Antimicrobial Chemotherapy;2024-01-03